HCWB
HCWB
NASDAQ · Biotechnology

Hcw Biologics Inc

$1.82
-0.11 (-5.70%)
As of Sep 28, 10:47 PM ET ·
Financial Highlights (FY 2026)
Revenue
403.3K
Net Income
-59,194,860
Gross Margin
20.0%
Profit Margin
-14,677.7%
Rev Growth
-79.9%
D/E Ratio
2.46
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.0% 20.0% 30.6% 30.6%
Operating Margin -14,201.5% -12,781.3% -4.2% -3.9%
Profit Margin -14,677.7% -13,943.8% -5.3% -5.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 403.3K 2.01M 478.0K 424.9K
Gross Profit 80.6K 401.9K 146.1K 129.9K
Operating Income -57,270,206 -256,945,091 -20,310 -16,746
Net Income -59,194,860 -265,580,129 -25,168 -22,690
Gross Margin 20.0% 20.0% 30.6% 30.6%
Operating Margin -14,201.5% -12,781.3% -4.2% -3.9%
Profit Margin -14,677.7% -13,943.8% -5.3% -5.3%
Rev Growth -79.9% -79.9% +3.1% +2.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.53M 1.53M 286.1K 295.5K
Total Equity 623.2K 623.2K 2.68M 2.44M
D/E Ratio 2.46 2.46 0.11 0.12
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -55,511,870 -262,892,704 -28,783 -26,607
Free Cash Flow — — -23,138 -19,951